Concepedia

Philip K. Tan

PK

15

Publications

1.2K

Citations

14

H-Index

1993

Active since

Affiliations

University of California, San Francisco(Current)

Harvard University

University of California, Los Angeles

AstraZeneca (United States)

Philip K. Tan is an author at University of California, San Francisco specializing in medicine, intracellular trafficking, and cellular biochemistry.

Top concepts

Publications per year

1993–2017

15

Publications

15

Clathrin facilitates the internalization of seven transmembrane segment receptors for mating pheromones in yeast.

Philip K. Tan, Nicholas G. Davis, G. F. Sprague et al. · The Journal of Cell Biology · 1993 · 148 citations · Full text

, , +18

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney

Jeffrey N. Miner, Philip K. Tan, David Hyndman et al. · Arthritis Research & Therapy · 2016 · 124 citations · Full text

A Leucine-based Motif Mediates the Endocytosis of Vesicular Monoamine and Acetylcholine Transporters

Philip K. Tan, Clarissa L. Waites, Yongjian Liu et al. · Journal of Biological Chemistry · 1998 · 117 citations · Full text

, , +18

Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout

Philip K. Tan, Sha Liu, Esmir Gunić et al. · Scientific Reports · 2017 · 112 citations · Full text

The sequence NPFXD defines a new class of endocytosis signal in Saccharomyces cerevisiae.

Philip K. Tan, James P. Howard, Gregory S. Payne · The Journal of Cell Biology · 1996 · 108 citations · Full text

, , +20

Rows per page

1–5 of 15